๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-01-30

The Young Women's Breast Cancer Study (NCT01468246)

๐Ÿ”ต Active, Not Recruiting Interventional Protocol ๐Ÿ“Š Observational Clinical Research Sponsor: Dana-Farber Cancer Institute

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The investigators are conducting a longitudinal cohort study of young women with breast cancer. The investigators identify women age 40 and younger with newly-diagnosed breast cancer from academic and community healthcare institutions. After women consent to the study, they fill-out surveys and give blood samples, and the investigators collect tissue from their breast cancer tumor after it is removed. Women are surveyed every 6 months for the first 3 years after diagnosis, then yearly thereafter for an additional 7 years (for a total follow-up of at least 10 years following diagnosis). The study investigates short and long-term disease and treatment issues, tumor biology and the relationship to patient outcomes, and psychosocial concerns at baseline and in follow-up among a cohort of young women who are newly-diagnosed with breast cancer.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (3 items).

Location: University of Colorado Cancer Center โ€” Aurora, Colorado

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Usually NOT eligible if any of the following apply:

  • Exclusion Criteria:
  • Inability to understand written and spoken English to the extent necessary to complete the questionnaires
  • Absence of informed consent

๐Ÿ” Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

๐Ÿ“ All Participating Trial Locations (13 Sites)

  • University of Colorado Cancer Center โ€” Aurora, Colorado
  • Beth-Israel Deaconess Medical Center โ€” Boston, Massachusetts
  • Dana-Farber Cancer Institute โ€” Boston, Massachusetts
  • Massachusetts General Hospital โ€” Boston, Massachusetts
  • MGH/North Shore Cancer Center โ€” Danvers, Massachusetts
  • Cape Cod Hospital โ€” Hyannis, Massachusetts
  • Lowell General Hospital โ€” Lowell, Massachusetts
  • DF/BWCC at Milford Regional Medical Center โ€” Milford, Massachusetts
  • Newton-Wellesley Hospital โ€” Newton, Massachusetts
  • South Shore Hospital โ€” South Weymouth, Massachusetts
  • Mayo Clinic โ€” Rochester, Minnesota
  • Dana-Farber/New Hampshire Oncology-Hematology โ€” Londonderry, New Hampshire
  • Sunnybrook Health Sciences Centre โ€” Toronto, Ontario

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
๐Ÿ›๏ธ View Official NIH Record โ†—